The legal cannabis market has been on the rise for quite some time. Statistics published in Stellar Market Research’s new report indicate that the industry is set to continue skyrocketing. The market was valued at USD $28.26 billion in 2021, and total revenue is predicted to surge at a compound annual growth rate (CAGR) of 32.04% between 2022 and 2027.
According to industry analysts, the cannabis market will soar to a valuation of $149.8 billion by the year 2027. The new report examines market growth drivers and segments. Several notable participants provided data for the report, highlighting a handful of dominant regions, including APAC, Europe, MEA, North America, and South America.
Key data analysis featured in the report extends over a three-year historical period from 2017-2020. In addition to the unique cannabis markets, challenges, growth drivers, limitations, and opportunities featured in Stellar Market Research’s detailed analysis, the report also features investor recommendations.
Researchers from Stellar Market Research have outlined several key factors stimulating industry success, including increasing disposable incomes. According to the report, the increasingly aging population and illness amplify the demand for medicinal cannabis. Older adults face a higher risk of developing chronic diseases, such as arthritis, cancer, epilepsy, and migraines. As a result, more physician visits are necessary.
The researchers also spotlighted rising demand in the agriculture sector for legal cannabis. Pesticides can be created using recreational cannabis, thus offering agricultural workers the opportunity to utilize a less harmful option than conventional pesticides.
Furthermore, the report emphasizes that cannabis offers a safer alternative to traditional treatment options and produces fewer adverse side effects. Additionally, cannabis-based medicines allow patients to minimize their opioid dosage and frequency while still benefiting from pain relief.
As a plant that is shrouded in misconception, many governments are outlawing the use of cannabis. Even though cannabis is permitted in specific regions of Africa, Europe, North America, and South America, it is still forbidden by law in the majority of Middle Eastern and Asian countries, including Japan, India, and Korea. Due to these strict regulations, consumption, possession, purchase, and sale are deemed criminal acts. Consequently, cannabis market growth is somewhat restricted.
The potentially adverse side effects of specific cannabis strains—particularly those rich in the psychoactive compound delta-9 tetrahydrocannabinol (THC)—hinder market growth. The Stellar Market Research team also noted the addictive nature of cannabis as one of the restraints to the cannabis market. While cannabis is believed to be non-addictive, dependence on the plant has been explicitly documented.
Cannabis legalization is unfolding across the Asia Pacific region—something that has been largely stimulated by the rise of legal cannabis across most nations in Europe, North America, and South America. China, which already boasts a significant market for industrial hemp, is expected to emerge as a serious contender for industrial cannabis in the foreseeable future.
A focal point of the report was that many key players in the cannabis businesses are patiently waiting for legislative advancement in the Asia Pacific area. If and when this happens, numerous countries across the region stand to reap the rewards of large-capacity, low-cost production. Researchers believe that this will open up immense opportunities for legal cannabis.
To achieve a clearer understanding of growth drivers in the legal cannabis industry, researchers segmented the market as follows:
Some of the key takeaways of this report were as follows:
Click here to read the full cannabis market report from Stellar Market Research.
Have you ever consumed cannabis and gotten a little too high for your liking? Or have you ever needed to calm down a friend who consumed too much weed for their tolerance level? If so, we’ve got you covered. Although an overdose (taking more than what is medically recommended) of delta-9 tetrahydrocannabinol (THC) is not…
Cannabis tinctures are relatively new on the scene compared to the long, thousands-year-old history of the cannabis plant itself. It was first recognized for its medicinal use in European medicine in 1839, and by 1851, medicinal cannabis tinctures had made their way into a drug almanac known as the United States Pharmacopeia. Despite prohibition throughout…
When Piper Lindeen’s son Zach began showing medical issues at just three years old, no one suspected a rare, severe form of epilepsy. Doctors initially didn’t recognize his symptoms as seizures. Eventually, they diagnosed Zach with epilepsy—but by then, his condition had worsened from a few seizures a week to several each day. As it…
Over the years, Hollywood has had a mixed relationship with cannabis. Portrayals have run the gamut from weed as the devil’s lettuce, able to ruin your life and destroy your mind after just a single puff, to a beneficial, life-giving MacGuffin. Because American audiences have such wide-ranging attitudes towards weed— according to the Pew Research…
You may think that when someone has a medical cannabis card, they are able to use cannabis however their medical practitioner sees fit. However, this is not always the case! Depending on someone’s employment and place of work, they may not be able to use cannabis, even if they were to obtain a medical cannabis…
Sign up for our newsletter
Get your medical marijuana card today
Sign up in under 5 minutes
Start By Selecting Your State
